Eat, explore, rest: a leptin-sensing brain circuit helps overcome anxiety to meet vital needs
2025-10-20
(Press-News.org)
How do mammals manage to eat in situations that cause anxiety, step into exposed spaces, or slow down when anxiety drives them to keep moving? A new study pinpoints a leptin-sensitive circuit in the lateral hypothalamus that helps to overcome anxiety to perform essential behaviours such as exploring, feeding, and limiting maladaptive hyperactivity. Leptin is a hormone that acts in the brain, regulating energy balance, influencing appetite and eating behaviour. Leptin is sensed by neurons which have leptin receptors. Many of these neurons are located in the lateral hypothalamus, the brain region where metabolic signals come together. It is responsible for the regulation of eating behaviour. The study “A lateral hypothalamic neuronal population expressing leptin receptors counteracts anxiety to enable adaptive behavioral responses”, headed by Professor Dr Tatiana Korotkova, director of the University of Cologne’s Institute for Systems Physiology and Principal Investigator at the CECAD Cluster of Excellence on Aging Research, has appeared in Nature Neuroscience.
Anxiety is a protective state that helps us to avoid harmful conditions. Yet, anxiety can also block us from pursuing vital needs like eating and, in some cases, can even lead to maladaptive behaviours such as excessive exercise in anorexia nervosa. Because the hypothalamus and its core circuitry are evolutionarily conserved between mice and humans, delineating leptin-sensitive lateral hypothalamic mechanisms could provide a foundation for clinical translation and drug development. In the mouse model, the team shows that activity in leptin-sensing lateral hypothalamic neurons predicts an individual’s anxiety state and can be tuned to restore adaptive choices even under conditions that cause anxiety.
The researchers used tiny microscopes to visualize the activity of individual neurons while the mice freely explored different environments and engaged in various spontaneous behaviours. “We imaged the activity of leptin-sensing neurons while mice faced situations that might cause anxiety. We saw that these neurons get activated whenever animals overcame anxiety and freely explored exposed areas or approached food within them,” says Rebecca Figge-Schlensok, a doctoral researcher at the University of Cologne. “When we boosted this activity, mice explored more and were able to eat in challenging contexts – clear signs that this circuit helps push past anxiety to support adaptive, goal-directed behaviour.”
The researchers further observed increased input from the prefrontal cortex – a region that mediates cognitive control – in more anxious animals. This input supressed the activity of anxiety-reducing cells, thereby preventing relief from anxiety. This demonstrates a role of cognitive control in the regulation of emotional states. “What excited us is that the activity of these leptin-sensing neurons doesn’t just track state – it predicts which individual will be more or less anxious in a challenging situation,” notes Dr Anne Petzold, co-first author, currently a group leader at the European Neuroscience Institute, Göttingen. “Increased input from the prefrontal cortex provided a mechanistic handle for why more anxious individuals fail to recruit this anxiety-reducing circuit.”
Anxiety has clear clinical intersections, notably with anorexia nervosa. To investigate the therapeutic potential of the anxiety-relieving, leptin-sensitive neurons for the treatment of anorexia nervosa, the team turned to a preclinical anorexia nervosa disease model: the activity-based anorexia model. In this paradigm, mice with scheduled access to food and a freely accessible running wheel spontaneously develop excessive exercise levels. This symptom, often observed in anorexia nervosa patients, can transiently relieve anxiety, but worsens negative energy balance. Boosting the activity of leptin-sensing lateral hypothalamic neurons reduced excessive exercise to baseline levels, uncoupling anxiety from compensatory running.
This observation points to an anxiety-reducing, energy-preserving mechanism: “Anxiety and anorexia nervosa often go hand in hand – and anorexia has the highest mortality rate of any psychiatric disorder, with no effective pharmacological treatment to date,” says senior author Tatiana Korotkova. “By identifying a leptin-sensitive hypothalamic node that restrains anxiety-driven locomotion without suppressing normal activity, we begin to understand how emotional state and energy balance intersect in the brain. The next step is to test whether pharmacological modulation of these neurons could help treat anxiety and eating disorders.”
This research was supported by the ERC Consolidator Grant HypFeedNet, the German Research Foundation (DFG), the Cluster of Excellence on Aging Research (CECAD), Collaborative Research Centre 1451 “Key Mechanisms of Motor Control in Health and Disease”, and the Center for Molecular Medicine Cologne (CMMC).
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-10-20
In the right combinations and conditions, two-dimensional materials can host intriguing and potentially valuable quantum phases, like superconductivity and unique forms of magnetism. Why they occur, and how they can be controlled, is of considerable interest among physicists and engineers. Research published in Nature Physics reveals a previously hidden feature that could explain how and why enigmatic quantum phases emerge.
Using a new terahertz (THz) spectroscopic technique, the researchers revealed that tiny stacks of 2D materials, found in research labs around the world, can naturally form what are known as cavities. These cavities confine light and electrons into even ...
2025-10-20
Bethesda, MD (Oct. 17, 2025) — The American Gastroenterological Association (AGA) today released a new clinical practice guideline on the surveillance of Barrett's esophagus, the only known precursor to esophageal cancer (adenocarcinoma), a highly lethal cancer whose incidence has risen substantially over recent decades. The guideline provides eight evidence-based recommendations and several key implementation statements to help clinicians monitor patients after a diagnosis of Barrett's esophagus, a condition associated with chronic ...
2025-10-20
By the time patients start seeking care for multiple sclerosis (MS), the disease has already been damaging their brains for years. But until recently, scientists didn’t understand which brain cells were being targeted or when the injury began.
Now, by analyzing thousands of proteins found in the blood, scientists at UC San Francisco have created the clearest picture yet of when the disease attacks the myelin sheath that covers the nerve fibers. It shows that the immune system begins attacking ...
2025-10-20
Some ancient marine organisms produced mysterious magnetic particles of unusually large size, which can now be found as fossils in marine sediments. An international team has succeeded in mapping the magnetic domains on one of such ‘giant magnetofossils’ using a sophisticated method at the Diamond X-ray source. Their analysis shows that these particles could have allowed these organisms to sense tiny variations in both the direction and intensity of the Earth’s magnetic field, enabling them to geolocate themselves and ...
2025-10-20
Embargoed until 4 a.m. CT / 5 a.m. ET Monday, Oct. 20, 2025
DALLAS, Oct. 20, 2025 — About 9 in 10 U.S. adults have not heard of cardiovascular-kidney-metabolic (CKM) syndrome, a newly defined health condition affecting nearly 90% of adults that includes heart disease, kidney disease, diabetes and obesity, according to a new survey from the American Heart Association, a relentless force changing the future of health for everyone everywhere. However, many are interested in learning more about it.
Nearly 90% of U.S. adults have at least ...
2025-10-20
PITTSBURGH, October 20, 2025 — Doctors and researchers at the University of Pittsburgh and UPMC have developed a new treatment for epilepsy patients who don’t respond to medication and aren’t candidates for surgery. Their approach, published today in Nature Communications, uses deep brain stimulation (DBS) that is tailored to each patient’s unique brain wiring.
Epilepsy affects more than 50 million people worldwide, and about a third of those do not respond to medication. For some, seizures are generated in parts of the brain that control essential functions – speech, movement or vision – that can’t be safely removed. Brain ...
2025-10-20
If you’ve ever added liquid to a hot frying pan, maybe you noticed how the droplets bubbled up and skittered across the sizzling surface, rather than immediately flattening and wetting. This happens because the pan’s heat starts boiling the undersides of the droplets, producing vapor that acts as an insulating cushion on which they can – momentarily – dance.
Previously, scientists have produced a room-temperature version of this phenomenon – known as the Leidenfrost effect – ...
2025-10-20
Note: Abstract #6267, titled ECOG-ACRIN EA6174: Surgically Treated Adjuvant Merkel Cell Carcinoma with Pembrolizumab, is scheduled to be presented during the European Society for Medical Oncology meeting on Monday, Oct. 20, at 2:30 a.m. ET in the Cologne Auditorium, Messe Berlin, Berlin.
A drug that harnesses the immune system to attack cancer cells has proved successful in preventing a rare and aggressive form of skin cancer from spreading to other organs when given immediately after surgery, a new study shows.
Led by researchers at NYU ...
2025-10-20
A new cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) shows that a drug that utilizes the body’s immune system to target and eliminate cancer cells appeared to reduce the risk of distant metastases for an aggressive form of skin cancer when given immediately after surgery, but did not significantly reduce the overall risk of recurrence, which was a co-primary endpoint of the trial. The randomized phase 3 STAMP trial (EA6174) is the largest clinical study to date evaluating pembrolizumab, ...
2025-10-20
New research reveals that the number and complexity of cancer clinical trials since 2001 have varied across low- and middle-income countries (LMICs), with economic growth contributing to disparities, but only to a certain extent. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.
Although LMICs are expected to experience the greatest global burden of cancer in the coming years, cancer clinical trials are disproportionally concentrated in high-income countries. Because evidence suggests that LMICs have increased the number of cancer clinical trials over the last few decades, researchers investigated disparities ...
LAST 30 PRESS RELEASES:
[Press-News.org] Eat, explore, rest: a leptin-sensing brain circuit helps overcome anxiety to meet vital needs